Published in EJIFCC on April 20, 2009
Prevalence of microalbuminuria and its correlates among diabetic patients attending diabetic clinic at National Guard Hospital in Alhasa. J Family Community Med (2017) 0.75
Biochemistry and molecular cell biology of diabetic complications. Nature (2001) 25.43
Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78
Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med (1991) 3.81
The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol (2008) 3.64
Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med (2002) 3.57
Diabetes complications: why is glucose potentially toxic? Science (1996) 3.34
Podocyte biology and response to injury. J Am Soc Nephrol (2002) 3.25
From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes (2005) 3.10
Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol (2004) 2.44
Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol (2005) 2.25
Diabetic nephropathy in 27,805 children, adolescents, and adults with type 1 diabetes: effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex. Diabetes Care (2007) 2.18
Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes (2003) 2.17
Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev (2008) 2.14
Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes (1995) 2.12
Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival. J Am Soc Nephrol (2006) 2.10
Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet (1998) 2.02
Molecular mechanisms of diabetic renal hypertrophy. Kidney Int (1999) 1.91
Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy. Diabetes (2003) 1.91
Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes (1998) 1.90
Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes (2007) 1.79
Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol (2001) 1.75
Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes (2005) 1.75
Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol (2007) 1.69
A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med (1993) 1.68
Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes (2002) 1.67
Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol (2006) 1.67
The early natural history of nephropathy in Type 1 Diabetes: III. Predictors of 5-year urinary albumin excretion rate patterns in initially normoalbuminuric patients. Diabetes (2005) 1.67
Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int (2007) 1.63
Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol (2004) 1.59
Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int (2006) 1.59
Mechanisms of disease: the hypoxic tubular hypothesis of diabetic nephropathy. Nat Clin Pract Nephrol (2008) 1.52
Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. J Am Soc Nephrol (2006) 1.50
Pathogenesis of diabetic nephropathy. Exp Clin Endocrinol Diabetes (2001) 1.42
Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia (2002) 1.40
Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia (1990) 1.37
Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int (2007) 1.36
Intravenous administration of hepatocyte growth factor gene ameliorates diabetic nephropathy in mice. J Am Soc Nephrol (2004) 1.36
Genetic variation at the ACE gene is associated with persistent microalbuminuria and severe nephropathy in type 1 diabetes: the DCCT/EDIC Genetics Study. Diabetes (2005) 1.34
Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis (1999) 1.33
Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney Int (2002) 1.32
Microvascular basement membranes in diabetes mellitus. J Pathol (2003) 1.30
Plasma prorenin activity and complications in children with insulin-dependent diabetes mellitus. N Engl J Med (1990) 1.27
Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int (2004) 1.26
Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol (1999) 1.24
Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest (1995) 1.23
Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat. J Am Soc Nephrol (2003) 1.23
Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes (1989) 1.22
High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int (2005) 1.19
Molecular mechanisms of diabetic nephropathy and its therapeutic intervention. Curr Drug Targets (2007) 1.19
Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus. J Clin Invest (1992) 1.18
Diabetic nephropathy: Linking histology, cell biology, and genetics. Kidney Int (2004) 1.13
Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy. Am J Kidney Dis (2005) 1.11
Urinary tumor necrosis factor contributes to sodium retention and renal hypertrophy during diabetes. Am J Physiol Renal Physiol (2002) 1.09
Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians. J Diabetes Complications (2007) 1.08
Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int (1991) 1.05
Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy. Am J Nephrol (2007) 1.02
Angiotensin-converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus and its relationship with diabetic nephropathy. Kidney Int (1997) 1.02
Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Eur J Endocrinol (2004) 1.00
Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes (1994) 1.00
Association between the angiotensin-converting enzyme-insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. J Am Soc Nephrol (1998) 1.00
Regulation of renal proximal tubular epithelial cell hyaluronan generation: implications for diabetic nephropathy. Kidney Int (2001) 0.99
Renin/prorenin receptors. Kidney Int (2006) 0.96
Roles of lipid mediators in kidney injury. Semin Nephrol (2007) 0.94
The United States Renal Data System's 1991 annual data report: an introduction. Am J Kidney Dis (1991) 0.94
Impact of mitochondrial ROS production on diabetic vascular complications. Diabetes Res Clin Pract (2007) 0.93
Role of oxidative stress in diabetic nephropathy. Adv Chronic Kidney Dis (2005) 0.93
Eicosanoids and renal vascular function in diseases. Clin Sci (Lond) (2006) 0.92
Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes (1996) 0.92
Effect of glycated proteins on the matrix of glomerular epithelial cells. J Am Soc Nephrol (1998) 0.92
Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats. Am J Nephrol (2004) 0.88
The development of lesions in the glomerular basement membrane and mesangium after transplantation of normal kidneys to diabetic patients. Diabetes (1983) 0.87
Genetic factors in the development of diabetic nephropathy. J Lab Clin Med (1995) 0.85
Advanced glycation end-products in diabetic nephropathy. Nephrol Dial Transplant (1999) 0.83
[Expression of VEGF in kidney of diabetic rats]. Sichuan Da Xue Xue Bao Yi Xue Ban (2007) 0.79
The clinical course of renal function in NIDDM patients with normo- and microalbuminuria. J Intern Med (1997) 0.78
Plasma prorenin as an early marker of nephropathy in diabetic (IDDM) adolescents. Kidney Int (1994) 0.78
Type 2 diabetic nephropathy: never too early to treat? J Am Soc Nephrol (2005) 0.76
Abnormalities in protein kinase C and MAP kinase cascade in mesangial cells cultured under high glucose conditions. J Diabetes Complications (1996) 0.76
Application of gene therapy to diabetic nephropathy. Kidney Int Suppl (1997) 0.75
Impact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary intervention. Pharmacogenomics (2011) 0.88
Chronic stress reduces the number of GABAergic interneurons in the adult rat hippocampus, dorsal-ventral and region-specific differences. Hippocampus (2014) 0.87
Protein interference in thyroid assays: an in vitro study with in vivo consequences. Clin Chim Acta (2005) 0.87
Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population. Cell Biochem Funct (2011) 0.83
O-GlcNAc modification of proteins affects volume regulation in Jurkat cells. Eur Biophys J (2009) 0.81
Microparticles and acute renal dysfunction in septic patients. J Crit Care (2012) 0.81
Serum thyroglobulin antibody levels within or near to the reference range may interfere with thyroglobulin measurement. Biochem Med (Zagreb) (2012) 0.80
Acylcarnitine esters profiling of serum and follicular fluid in patients undergoing in vitro fertilization. Reprod Biol Endocrinol (2013) 0.80
L-arginine metabolism in early-onset and late-onset pre-eclamptic pregnancies. Scand J Clin Lab Invest (2013) 0.80
Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary. Ideggyogy Sz (2007) 0.79
Urinary orosomucoid: a novel, early biomarker of sepsis with promising diagnostic performance. Clin Chem Lab Med (2016) 0.78
Metabolic hormones in follicular fluid in women undergoing in vitro fertilization. J Reprod Med (2013) 0.78
Lithium induces ER stress and N-glycan modification in galactose-grown Jurkat cells. PLoS One (2013) 0.77
Activated platelet-derived microparticle numbers are elevated in patients with severe fungal (Candida albicans) sepsis. Ann Clin Biochem (2012) 0.77
Challenges in the evaluation of D-dimer and fibrinogen levels in pregnant women. Thromb Res (2013) 0.77
A validated method for measurement of serum total, serum free, and salivary cortisol, using high-performance liquid chromatography coupled with high-resolution ESI-TOF mass spectrometry. Anal Bioanal Chem (2014) 0.77
Serum and follicular fluid fetuin-A in women undergoing in vitro fertilization. Clin Chem Lab Med (2014) 0.76
Progestin-dependent effect of oral contraceptives on plasma aldosterone/renin ratio. Clin Biochem (2012) 0.75
The effect of sample storage on the reliability of thyroglobulin and thyroglobulin-antibody measurements. Clin Biochem (2008) 0.75
Macroprolactinemia: the consequences of a laboratory pitfall. Endocrine (2003) 0.75